Lewis A. Duncan

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.

Sarah E. Jones, M W Schottstaedt, Lewis A. Duncan et al. · Journal of Clinical Oncology · 1996 · 52 citations

Malignant Glucagonoma Syndrome: Response to Chemotherapy

Samuel P. Marynick, Warren R. Fagadau, Lewis A. Duncan · Annals of Internal Medicine · 1980 · 44 citations

Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophosphamide in Stage II and III Breast Cancer

Stephen E. Jones, Pankaj Khandelwal, Kristi McIntyre et al. · Journal of Clinical Oncology · 1999 · 15 citations